Guru Subramanian Guru Murthy

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Guru Subramanian Guru Murthy

Showing results (21-30 of 51) with videos related to

Pageof 6

Sort By:

Hematology (Amsterdam, Netherlands)|September 3, 2014

Outcomes of immunosuppressant therapy with lower dose of antithymocyte globulin and cyclosporine in aplastic anemiaPankaj Malhotra, Vijay Bodh, Guru Subramanian Guru Murthy, et al.

Journal of the National Comprehensive Cancer Network : JNCCN|February 6, 2020

Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER DatabaseGuru Subramanian Guru Murthy, Aniko Szabo, Laura Michaelis, et al.

Biomarker Research|January 25, 2024

Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantationGuru Subramanian Guru Murthy, Tao Zhang, Yung-Tsi Bolon, et al.

Case Reports in Hematology|November 16, 2016

Reactivation of Pulmonary Tuberculosis following Treatment of Myelofibrosis with RuxolitinibMaheen Z Abidi, Javeria Haque, Parvathi Varma, et al.

Clinical Lymphoma, Myeloma & Leukemia|February 5, 2017

Autologous Hematopoietic Cell Transplantation in Patients With Multiple Myeloma: Effect of AgeBinod Dhakal, Ariel Nelson, Guru Subramanian Guru Murthy, et al.

Haematologica|January 30, 2025

40 is the new 50: reducing the need for platelet transfusions prior to lumbar puncture in adults with hematologic malignanciesKristen Corrao, Adrian Umpierrez, Angela Treml, et al.

Blood Advances|June 18, 2024

Outpatient administration of CAR T-cell therapies using a strategy of no remote monitoring and early CRS interventionFateeha Furqan, Vineel Bhatlapenumarthi, Binod Dhakal, et al.

Transplantation and Cellular Therapy|July 5, 2023

Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid LeukemiaMuhammad Bilal Abid, Noel Estrada-Merly, Mei-Jie Zhang, et al.

Ejhaem|August 19, 2024

Real-world outcomes of intensive induction approaches in core binding factor acute myeloid leukemiaAlexandra E Rojek, Benjamin J McCormick, Joanna Cwykiel, et al.

Leukemia|February 15, 2025

Phase 1 study of lintuzumab-Ac225 combined with CLAG-M salvage therapy in relapsed/refractory acute myeloid leukemiaSameem M Abedin, Guru Subramanian Guru Murthy, Mehdi Hamadani, et al.

Pageof 6

Search research articles

Showing results (21-30 of 51) with videos related to

Sort By:

Pageof 6

Hematology (Amsterdam, Netherlands)|September 3, 2014

Outcomes of immunosuppressant therapy with lower dose of antithymocyte globulin and cyclosporine in aplastic anemiaPankaj Malhotra, Vijay Bodh, Guru Subramanian Guru Murthy, et al.

Journal of the National Comprehensive Cancer Network : JNCCN|February 6, 2020

Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER DatabaseGuru Subramanian Guru Murthy, Aniko Szabo, Laura Michaelis, et al.

Biomarker Research|January 25, 2024

Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantationGuru Subramanian Guru Murthy, Tao Zhang, Yung-Tsi Bolon, et al.

Case Reports in Hematology|November 16, 2016

Reactivation of Pulmonary Tuberculosis following Treatment of Myelofibrosis with RuxolitinibMaheen Z Abidi, Javeria Haque, Parvathi Varma, et al.

Clinical Lymphoma, Myeloma & Leukemia|February 5, 2017

Autologous Hematopoietic Cell Transplantation in Patients With Multiple Myeloma: Effect of AgeBinod Dhakal, Ariel Nelson, Guru Subramanian Guru Murthy, et al.

Haematologica|January 30, 2025

40 is the new 50: reducing the need for platelet transfusions prior to lumbar puncture in adults with hematologic malignanciesKristen Corrao, Adrian Umpierrez, Angela Treml, et al.

Blood Advances|June 18, 2024

Outpatient administration of CAR T-cell therapies using a strategy of no remote monitoring and early CRS interventionFateeha Furqan, Vineel Bhatlapenumarthi, Binod Dhakal, et al.

Transplantation and Cellular Therapy|July 5, 2023

Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid LeukemiaMuhammad Bilal Abid, Noel Estrada-Merly, Mei-Jie Zhang, et al.

Ejhaem|August 19, 2024

Real-world outcomes of intensive induction approaches in core binding factor acute myeloid leukemiaAlexandra E Rojek, Benjamin J McCormick, Joanna Cwykiel, et al.

Leukemia|February 15, 2025

Phase 1 study of lintuzumab-Ac225 combined with CLAG-M salvage therapy in relapsed/refractory acute myeloid leukemiaSameem M Abedin, Guru Subramanian Guru Murthy, Mehdi Hamadani, et al.

Pageof 6